Lyme neuroborreliosis and dementia

Journal of Alzheimer's Disease

Volumn 41, Issue 4, 2014, Pages 1087-1093

  Blanc, Frederic ^a,b   Philippi, Nathalie ^a,b   Cretin, Benjamin ^a,b   Kleitz, Catherine ^a   Berly, Laetitia ^a   Jung, Barbara ^a,b   Kremer, Stephane ^a,b   Namer, Izzie Jacques ^a,b   Sellal, François ^a,c   Jaulhac, Benoit ^a   De Seze, Jerome ^a,d  

^a UNIVERSITY HOSPITAL OF STRASBOURG   (France)

^b UNIVERSITÉ DE STRASBOURG   (France)

^c General Hospital of Colmar   (France)

^d INSERM   (France)

Author keywords

Alzheimer's disease; dementia; frontotemporal lobe dementia; hippocampal sclerosis; intrathecal anti Borrelia antibody index; Lewy body dementia; Lewy body disease; Lyme disease; Lyme neuroborreliosis; vascular dementia

Indexed keywords

CEFTRIAXONE; FLUORODEOXYGLUCOSE F 18; IMMUNOGLOBULIN G; TAU PROTEIN; ANTIINFECTIVE AGENT;

ADULT; AGED; ALZHEIMER DISEASE; ANTIBIOTIC THERAPY; ARTICLE; CEREBROSPINAL FLUID ANALYSIS; CLINICAL ARTICLE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIFFUSE LEWY BODY DISEASE; DSM-IV; DSM-IV-TR; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; FRONTOTEMPORAL DEMENTIA; GENERAL CONDITION DETERIORATION; HIPPOCAMPAL SCLEROSIS; HUMAN; LYME DISEASE; MALE; MULTIINFARCT DEMENTIA; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RARE DISEASE; WESTERN BLOTTING; BRAIN; CEREBROSPINAL FLUID; DEMENTIA; DIAGNOSTIC USE; LYME NEUROBORRELIOSIS; MIDDLE AGED; PATHOLOGY; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BRAIN; DEMENTIA; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; LYME NEUROBORRELIOSIS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; POSITRON-EMISSION TOMOGRAPHY;

EID: 84920175977     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-130446     Document Type: Article

References (24)

1. Miklossy J (2008) Biology and neuropathology of dementia in syphilis and Lyme disease. Handb Clin Neurol 89, 825-844.
2. Halperin JJ, Volkman DJ, Wu P (1991) Central nervous system abnormalities in Lyme neuroborreliosis. Neurology 41, 1571-1582.
3. Logigian EL, Johnson KA, Kijewski MF, Kaplan RF, Becker JA, Jones KJ, Garada BM, Holman BL, Steere AC (1997) Reversible cerebral hypoperfusion in Lyme encephalopathy. Neurology 49, 1661-1670.
4. Blanc F, Jaulhac B, Fleury M, de Seze J, de Martino SJ, Remy V, Blaison G, Hansmann Y, Christmann D, Tranchant C (2007) Relevance of the antibody index to diagnose Lyme neuroborreliosis among seropositive patients. Neurology 69, 953-958.
5. Scheltens P, Barkhof F, Leys D, Pruvo JP, Nauta JJ, Vermersch P, Steinling M, Valk J (1993) A semiquantative rating scale for the assessment of signal hyperintensities on magnetic resonance imaging. J Neurol Sci 114, 7-12.
6. Dubois B, Feldman HH, Jacova C, Dekosky ST, Barberger-Gateau P, Cummings J, Delacourte A, Galasko D, Gauthier S, Jicha G,Meguro K, O'Brien J, Pasquier F, Robert P, Rossor M, Salloway S, Stern Y, Visser PJ, Scheltens P (2007) Research criteria for the diagnosis of Alzheimer's disease: Revising the NINCDS-ADRDA criteria. Lancet Neurol 6, 734-746.
7. McKeith IG, DicksonDW,Lowe J,EmreM, O'Brien JT, Feldman H, Cummings J, Duda JE, Lippa C, Perry EK, Aarsland D, Arai H, Ballard CG, Boeve B, Burn DJ, Costa D, Del Ser T, Dubois B, Galasko D, Gauthier S, Goetz CG, Gomez-Tortosa E, Halliday G, Hansen LA, Hardy J, Iwatsubo T, Kalaria RN, Kaufer D, Kenny RA, Korczyn A, Kosaka K, Lee VM, Lees A, Litvan I, Londos E, Lopez OL, Minoshima S, Mizuno Y, Molina JA, Mukaetova-Ladinska EB, Pasquier F, Perry RH, Schulz JB, Trojanowski JQ, YamadaM(2005) Diagnosis and management of dementia with Lewy bodies: Third report of the DLB Consortium. Neurology 65, 1863-1872.
8. Rascovsky K, Hodges JR, Knopman D, Mendez MF, Kramer JH, Neuhaus J, van Swieten JC, Seelaar H, Dopper EG, Onyike CU, Hillis AE, Josephs KA, Boeve BF, Kertesz A, Seeley WW, Rankin KP, Johnson JK, Gorno-Tempini ML, Rosen H, Prioleau-Latham CE, Lee A, Kipps CM, Lillo P, Piguet O, Rohrer JD, Rossor MN, Warren JD, Fox NC, Galasko D, Salmon DP, Black SE, Mesulam M,Weintraub S, Dickerson BC, Diehl-Schmid J, Pasquier F, Deramecourt V, Lebert F, PijnenburgY, ChowTW, Manes F, Grafman J, Cappa SF, Freedman M, Grossman M, Miller BL (2011) Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Brain 134, 2456-2477.
9. Barkhof F, Polvikoski TM, van Straaten EC, Kalaria RN, Sulkava R, Aronen HJ, Niinisto L, Rastas S, Oinas M, Scheltens P, Erkinjuntti T (2007) The significance of medial temporal lobe atrophy: A postmortem MRI study in the very old. Neurology 69, 1521-1527.
10. Pacheco e Silva AC (1926) Localisation du Treponema Pallidum dans le cerveau des paralytiques généraux. Revue Neurologique (Paris) 2, 558-565.
11. Eikeland R, Ljostad U, Mygland A, Herlofson K, Lohaugen GC (2012) European neuroborreliosis: Neuropsychological findings 30 months post-treatment. Eur J Neurol 19, 480-487.
12. Miklossy J (2011) Alzheimer's disease - a neurospirochetosis. Analysis of the evidence following Koch's and Hill's criteria. J Neuroinflammation 8, 90.
13. Miklossy J (2012) Chronic or late lyme neuroborreliosis: Analysis of evidence compared to chronic or late neurosyphilis. Open Neurol J 6, 146-157.
14. MacDonald AB, Miranda JM (1987) Concurrent neocortical borreliosis and Alzheimer's disease. Hum Pathol 18, 759-761.
15. Miklossy J, Khalili K, Gern L, Ericson RL, Darekar P, Bolle L, Hurlimann J, Paster BJ (2004) Borrelia burgdorferi persists in the brain in chronic lyme neuroborreliosis and may be associated with Alzheimer disease. J Alzheimers Dis 6, 639-649; discussion 673-681.
16. Amieva H, Le Goff M, Millet X, Orgogozo JM, Peres K, Barberger-Gateau P, Jacqmin-Gadda H, Dartigues JF (2008) Prodromal Alzheimer's disease: Successive emergence of the clinical symptoms. Ann Neurol 64, 492-498.
17. Bateman RJ, Xiong C, Benzinger TL, Fagan AM, Goate A, Fox NC, Marcus DS, Cairns NJ, Xie X, Blazey TM, Holtzman DM, Santacruz A, BucklesV, OliverA, Moulder K, Aisen PS, Ghetti B, Klunk WE, McDade E, Martins RN, Masters CL, Mayeux R, Ringman JM, Rossor MN, Schofield PR, Sperling RA, Salloway S, Morris JC (2012) Clinical and biomarker changes in dominantly inherited Alzheimer's disease. N Engl J Med 367, 795-804.
18. Villemagne VL, Burnham S, Bourgeat P, Brown B, Ellis KA, Salvado O, Szoeke C, Macaulay SL, Martins R, Maruff P, Ames D, Rowe CC, Masters CL (2013) Amyloid beta deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: A prospective cohort study. Lancet Neurol 12, 357-367.
19. Holmes C, Butchart J (2011) Systemic inflammation and Alzheimer's disease. Biochem Soc Trans 39, 898-901.
20. Pietri M, Dakowski C, Hannaoui S, Alleaume-Butaux A, Hernandez-Rapp J, Ragagnin A, Mouillet-Richard S, Haik S, Bailly Y, Peyrin JM, Launay JM, Kellermann O, Schneider B (2013) PDK1 decreases TACE-mediated alpha-secretase activity and promotes disease progression in prion and Alzheimer's diseases. Nat Med 19, 1124-1131.
21. Rasley A, Anguita J, Marriott I (2002) Borrelia burgdorferi induces inflammatory mediator production by murine microglia. J Neuroimmunol 130, 22-31.
22. Blanc F (2009) Epidemiology of Lyme borreliosis and neuroborreliosis in France. Rev Neurol (Paris) 165, 694-701.
23. de Jager CA, Honey TE, Birks J, Wilcock GK (2010) Retrospective evaluation of revised criteria for the diagnosis of Alzheimer's disease using a cohort with post-mortem diagnosis. Int J Geriatr Psychiatry 25, 988-997.
24. Nelson PT, Jicha GA, Kryscio RJ, Abner EL, Schmitt FA, Cooper G, Xu LO, Smith CD, Markesbery WR (2010) Low sensitivity in clinical diagnoses of dementia with Lewy bodies. J Neurol 257, 359-366.